Detalhes bibliográficos
Ano de defesa: |
2016 |
Autor(a) principal: |
Cardoso Filho, Leonardo Izidório
![lattes](/bdtd/themes/bdtd/images/lattes.gif?_=1676566308) |
Orientador(a): |
Santos, Silvia Helena Rabelo dos
![lattes](/bdtd/themes/bdtd/images/lattes.gif?_=1676566308) |
Banca de defesa: |
Santos, Silvia Helena Rabelo dos
,
Saddi, Vera Aparecida,
Carneiro, Megmar Aparecida dos Santos |
Tipo de documento: |
Dissertação
|
Tipo de acesso: |
Acesso aberto |
Idioma: |
por |
Instituição de defesa: |
Universidade Federal de Goiás
|
Programa de Pós-Graduação: |
Programa de Pós-graduação em Medicina Tropical e Saúde Publica (IPTSP)
|
Departamento: |
Instituto de Patologia Tropical e Saúde Pública - IPTSP (RG)
|
País: |
Brasil
|
Palavras-chave em Português: |
|
Palavras-chave em Inglês: |
|
Área do conhecimento CNPq: |
|
Link de acesso: |
http://repositorio.bc.ufg.br/tede/handle/tede/6538
|
Resumo: |
Introduction: cervical cancer is the third cause of women’s death by cancer in the world and its incidence is linked to high-risk oncogenic human papillomavirus (HPV). The cytodiagnosis and tracking of the disease are made by the Papanicolaou technique. Quality control programs have been implemented in order to correct errors of diagnosis, particularly with regard to false-negative results. Objective: to evaluate the internal quality control indicators and quality management program in the section of cytopathology of a university laboratory in the years 2007-2014. Methods: All results of cervical smears tests (taken from the SISCAN – Sistema de Informação do Câncer – The Cancer Information System) of women aged ≥15 years at the time of Pap smear specimen collection during January 2007 to December 2014. The final results of the cytopathology examinations were classified in accordance with the Bethesda System. The variables included in the database were woman’s name, date of birth, and age at time of collection (15–30, 31–40 and >40 years). Results: In this period 50,286 tests were carried out, 44,386 (91.34%) being negative for malignancy and 4,209 (8.66%) abnormal. The positivity rate was 8.69%; the percentage of tests consistent with ASC (Atypical Squamous Cells), between satisfactory exams was 4.12%; the percentage of tests compatible with ASC among abnormal tests was 47.87%; the ASC/SIL (Squamous Intraepithelial Lesion) ratio was 0.97 and the percentage of HSIL (High Grade intraepithelial Lesion squamous high degree) between satisfactory tests was 2.21%, and false-negative results in 5-years retrospective review was 4.97%. Conclusion: The rates obtained were uniforms over the years and within the recommended values. This demonstrates the efficiency and linearity of the internal quality control, reflected in the commitment of the team involved in, through continuing education, whose goal is to detect and correct false-negative results. |